BlackRock Institutional Trust’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$67.2M Buy
1,566,280
+89,892
+6% +$3.65M 0.01% 1154
2016
Q3
$60.9M Buy
1,476,388
+22,968
+2% +$962K 0.01% 1150
2016
Q2
$58M Buy
1,453,420
+2,652
+0.2% +$95.4K 0.01% 1151
2016
Q1
$48.9M Buy
1,450,768
+11,136
+0.8% +$347K 0.01% 1236
2015
Q4
$48.8M Buy
1,439,632
+41,956
+3% +$1.31M 0.01% 1255
2015
Q3
$41.6M Sell
1,397,676
-123,802
-8% -$3.87M 0.01% 1334
2015
Q2
$41.9M Sell
1,521,478
-90,018
-6% -$2.4M 0.01% 1399
2015
Q1
$40.6M Buy
1,611,496
+34,087
+2% +$806K 0.01% 1450
2014
Q4
$35M Sell
1,577,409
-12,822
-0.8% -$260K 0.01% 1536
2014
Q3
$32.3M Sell
1,590,231
-47,065
-3% -$937K 0.01% 1560
2014
Q2
$31.5M Buy
1,637,296
+50,874
+3% +$948K 0.01% 1644
2014
Q1
$29.8M Buy
1,586,422
+56,369
+4% +$1.09M 0.01% 1692
2013
Q4
$29.8M Buy
1,530,053
+169,663
+12% +$3.11M 0.01% 1637
2013
Q3
$22.4M Sell
1,360,390
-48,602
-3% -$780K ﹤0.01% 1778
2013
Q2
$21.1M Buy
+1,408,992
New +$20.6M ﹤0.01% 1774

Other funds holding IART

BlackRock Institutional Trust's IART Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Integra LifeSciences (IART) stake by 6.1% in Q4 2016, buying an estimated $3.65M and bringing the position to 1,566,280 shares worth $67.2M. The position accounts for 0.01% of the portfolio, ranked #1154.

BlackRock Institutional Trust first reported a position in IART in Q2 2013 and has held it in 15 quarters since. 224 funds tracked by Wall St. Rank hold IART as of Q4 2016.

  • BlackRock Institutional Trust held 1,566,280 shares of Integra LifeSciences worth $67.2M as of Q4 2016.
  • BlackRock Institutional Trust bought 89,892 Integra LifeSciences shares in Q4 2016, an estimated $3.65M.
  • Integra LifeSciences made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1154 holding.
  • BlackRock Institutional Trust first reported a position in Integra LifeSciences in Q2 2013 and has held it in 15 quarters since.
  • 224 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.